TrialInternational journal of radiation oncology, biology, physics2020

Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer.

John D Fenwick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.